{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:27:24Z","timestamp":1790515644438,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Stroke"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:p>\n            <jats:bold>\n              <jats:italic>Background and Purpose\u2014<\/jats:italic>\n            <\/jats:bold>\n            This study evaluated the safety and efficacy of aggressive mechanical clot disruption (AMCD) in acute stroke patients with persisting middle cerebral artery (MCA) or internal carotid artery (ICA) occlusion after thrombolytic therapy.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Methods\u2014<\/jats:italic>\n            <\/jats:bold>\n            Retrospective case series were used from a prospectively collected stroke database on consecutive acute ischemic stroke patients treated with intra-arterial (IA) thrombolytics and mechanical clot disruption during a 5-year interval. Thrombolytic dosage, endovascular techniques, immediate and final recanalization rates, symptomatic hemorrhage, mortality, and outcome were determined.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Results\u2014<\/jats:italic>\n            <\/jats:bold>\n            Thirty-two patients received AMCD. Median baseline National Institutes of Health Stroke Scale (NIHSS) score was 18, and median time to initiation of IA treatment was 261 minutes from symptom onset. ICA occlusion was noted in 16 patients and MCA occlusion in 16 patients: 22 received combined IV\/IA thrombolytics, 3 received IV thrombolytics, 6 received IA thrombolytics, and 1 patient received no thrombolytics before AMCD. No immediate periprocedural complications were noted. Immediate recanalization was achieved in 38% (50% MCA, 25% ICA) and final recanalization in 75% (88% MCA, 63% ICA) of patients. Favorable outcome occurred in 19 (59%) patients, symptomatic cerebral hemorrhage in 3 (9.4%) patients, and mortality in 4 (12.5%) patients.\n          <\/jats:p>\n          <jats:p>\n            <jats:bold>\n              <jats:italic>Conclusion\u2014<\/jats:italic>\n            <\/jats:bold>\n            AMCD can be performed safely with comparable intracerebral hemorrhage and mortality rates to other IA therapies even after use of intravenous thrombolytics in selected patients. Early deployment of this technique leads to immediate recanalization in one third of patients. AMCD may potentially shorten the time to flow restoration and improve overall recanalization rates achieved with IA therapy.\n          <\/jats:p>","DOI":"10.1161\/01.str.0000152331.93770.18","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T03:39:57Z","timestamp":1104377997000},"page":"292-296","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":164,"title":["Aggressive Mechanical Clot Disruption"],"prefix":"10.1161","volume":"36","author":[{"given":"Elizabeth A.","family":"Noser","sequence":"first","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashem M.","family":"Shaltoni","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiana E.","family":"Hall","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V.","family":"Alexandrov","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Garami","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin D.","family":"Cacayorin","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon K.","family":"Song","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Grotta","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Morgan S.","family":"Campbell","sequence":"additional","affiliation":[{"name":"From the Departments of Neurology (E.A.N., H.M.S., C.E.H., A.V.A., Z.G., J.C.G.), and Radiology (E.D.C.), University of Texas-Houston Medical School; the Institute for Neurology and Neurosurgery (J.K.S.), Beth Israel Hospital, New York, NY; and the Alabama Neurological Institute (M.S.C.), Birmingham."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_2_1_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332401"},{"key":"e_1_3_2_2_2","first-page":"41","volume":"49","year":"2001","unstructured":"Qureshi AI, Ali Z, Suri MF, Kim SH, Shatla AA, Ringer AJ, Lopes DK, Guterman LR, Hopkins LN. Intra-arterial third generation recombinant tissue plasminogen activator (reteplase) for acute ischemic stroke. Neurosurgery. 2001; 49: 41\u201348.","journal-title":"Neurosurgery"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.3.610"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.59.6.862"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000055940.00316.6b"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.1.4"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000121641.77121.98"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000082721.62796.09"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.21.2003"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.0000020363.23725.67"},{"key":"e_1_3_2_11_2","first-page":"352","volume":"22","year":"2001","unstructured":"Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J. Combined intraarterial\/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol. 2001; 22: 352\u2013358.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_12_2","first-page":"251","volume":"50","year":"2002","unstructured":"Suarez J, Zaidat O, Sunshine J, Tarr R, Selman W, Landis D. Endovascular Administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic stroke. Neurosurgery. 2002; 50: 251\u2013260.","journal-title":"Neurosurgery"},{"key":"e_1_3_2_13_2","first-page":"1282","volume":"48","year":"2001","unstructured":"Ringer AJ, Qureshi AI, Fessler RD, Guterman LR, Hopkins LN. Angioplasty of intracranial occlusion resistant to thrombolysis in acute ischemic stroke. Neurosurgery. 2001; 48: 1282\u20131290.","journal-title":"Neurosurgery"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.2.429"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.2.289"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199812000-00004"},{"key":"e_1_3_2_17_2","first-page":"208","volume":"20","year":"2001","unstructured":"Christou I, Burgin WS, Alexandrov AV, Grotta JC. Arterial status after intravenous TPA therapy for ischemic stroke. A need for further interventions. Int Angiol. 2001; 20: 208\u2013213.","journal-title":"Int Angiol"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.8.1812"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-200211000-00040"},{"key":"e_1_3_2_20_2","first-page":"1817","volume":"15","year":"1994","unstructured":"Barnwell SL, Clark WM, Nguyen TT, O\u2019Neil OR, Wynn ML, Coull BM. Safety and efficacy of delayed intraarterial urokinase therapy with mechanical clot disruption for thromboembolic stroke. AJNR Am J Neuroradiol. 1994; 15: 1817\u20131822.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.12.2568"},{"key":"e_1_3_2_22_2","first-page":"1308","volume":"23","year":"2002","unstructured":"Song JK, Cacayorin ED, Campbell MS, Fisher S, Malkoff MD., Alexandrov AV, Grotta JC. Intracranial balloon angioplasty of acute terminal internal carotid artery occlusion. AJNR Am J Neuroradiol. 2002; 23: 1308\u20131312.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_23_2","first-page":"1661","volume":"18","year":"1997","unstructured":"Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol. 1997; 18: 1661\u20131668.","journal-title":"AJNR Am J Neuroradiol"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-3019(98)00133-5"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.29.9.1894"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.31.5.1128"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1161\/str.21.4.2183404"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/jon199334242"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1159\/000069493"}],"container-title":["Stroke"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/01.STR.0000152331.93770.18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T21:37:35Z","timestamp":1715549855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/01.STR.0000152331.93770.18"}},"subtitle":["A Safe Adjunct to Thrombolytic Therapy in Acute Stroke?"],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1161\/01.STR.0000152331.93770.18"],"URL":"https:\/\/doi.org\/10.1161\/01.str.0000152331.93770.18","relation":{},"ISSN":["0039-2499","1524-4628"],"issn-type":[{"value":"0039-2499","type":"print"},{"value":"1524-4628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"2004-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-11-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2004-12-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}